Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
$EPAZ oversold here, due for a bounce!
Epazz Inc. is an enterprise-wide software company that specializes in providing customized web applications to the corporate world, higher education institutions and the public sector. Epazz’ unique BoxesOS applications can create virtual communities for enhanced communication, provide information and content for decision-making, and create a secure marketplace for any type of commerce all through the medium of the Internet. Epazz is the answer to the increasing information technology demand of the 21st century.
http://www.epazz.com/#
Epazz Inc. is an enterprise-wide software company that specializes in providing customized web applications to the corporate world, higher education institutions and the public sector. Epazz’ unique BoxesOS applications can create virtual communities for enhanced communication, provide information and content for decision-making, and create a secure marketplace for any type of commerce all through the medium of the Internet. Epazz is the answer to the increasing information technology demand of the 21st century.
http://www.epazz.com/#
EPAZ ~ Check Out The $EPAZ Facebook Page ~
https://www.facebook.com/epazz.investorsrelations?fref=ts
EPAZ ~ Check Out The $EPAZ Facebook Page ~
https://www.facebook.com/epazz.investorsrelations?fref=ts
EPAZ is generating a lot of buzz on Twitter.
EPAZ is generating a lot of buzz on Twitter.
EPAZ is on high alert. Watch for profits.
EPAZ is on high alert. Watch for profits.
EPAZ is on my radar.
EPAZ is on my radar.
EPAZ is acting bullish today.
EPAZ is looking for a green close.
EPAZ is looking for a green close.
$EPAZ is a leading provider of cloud-based business software solutions, announced that Intellisys’s SystemVIEW Cloud is completing over $50,000 worth of contracts for existing customers. The company is in the process of marketing the new product to new Vertical Markets. SystemVIEW Cloud will open up new revenue streams. Also the company is confirming that its support contracts renewal rates for Intellisys Software are well over the 90% level and is positioned to continue in this vein.
$EPAZ is a leading provider of cloud-based business software solutions, announced that Intellisys’s SystemVIEW Cloud is completing over $50,000 worth of contracts for existing customers. The company is in the process of marketing the new product to new Vertical Markets. SystemVIEW Cloud will open up new revenue streams. Also the company is confirming that its support contracts renewal rates for Intellisys Software are well over the 90% level and is positioned to continue in this vein.
$EPAZ oversold here, due for a bounce!
$EPAZ oversold here, due for a bounce!
Epazz Inc. is an enterprise-wide software company that specializes in providing customized web applications to the corporate world, higher education institutions and the public sector. Epazz’ unique BoxesOS applications can create virtual communities for enhanced communication, provide information and content for decision-making, and create a secure marketplace for any type of commerce all through the medium of the Internet. Epazz is the answer to the increasing information technology demand of the 21st century.
http://www.epazz.com/#
Epazz Inc. is an enterprise-wide software company that specializes in providing customized web applications to the corporate world, higher education institutions and the public sector. Epazz’ unique BoxesOS applications can create virtual communities for enhanced communication, provide information and content for decision-making, and create a secure marketplace for any type of commerce all through the medium of the Internet. Epazz is the answer to the increasing information technology demand of the 21st century.
http://www.epazz.com/#
EPAZ ~ Check Out The $EPAZ Facebook Page ~
https://www.facebook.com/epazz.investorsrelations?fref=ts
EPAZ ~ Check Out The $EPAZ Facebook Page ~
https://www.facebook.com/epazz.investorsrelations?fref=ts
EPAZ is on high alert. Watch for profits.
EPAZ is on high alert. Watch for profits.
EPAZ is on my radar today.
EPAZ is on my radar today.
BSGM Analysts forecast the global market for EP devices will grow at a 12.1 percent compound annual growth rate from $2.5 billion in 2012 to $5.5 billion by 2019 ? making it one of the fastest growing medical device segments. Just in the US, the number of AF and VT ablations is forecast to grow at 10.5 percent from 2012 to 2017.
BSGM According to the American Heart Association, AF increases an individual?s risk of stroke (fourth leading cause of death in the US) four to five-fold. AF is the most common arrhythmia with 2.7 million cases in 2010 in the U.S., forecast to grow to 5.6 million cases by 2050. In the US alone, AF leads to about 600,000 hospitalizations/year with a direct cost of about $6 billion annually and, adding indirect costs, brings the AF total cost to $26 billion.
BSGM According to the American Heart Association, AF increases an individual?s risk of stroke (fourth leading cause of death in the US) four to five-fold. AF is the most common arrhythmia with 2.7 million cases in 2010 in the U.S., forecast to grow to 5.6 million cases by 2050. In the US alone, AF leads to about 600,000 hospitalizations/year with a direct cost of about $6 billion annually and, adding indirect costs, brings the AF total cost to $26 billion.
BSGM These ablation procedures treat cardiac arrhythmias, which are broadly defined as a set of conditions in which the electrical activity of the heart is irregular, or faster or slower than normal. This type of heart disease afflicts 14.4 million Americans, or one in 18. Two of the most prevalent and deadly types of arrhythmias today are Atrial Fibrillation (AF) and Ventricular Tachycardia (VT).
BSGM These ablation procedures treat cardiac arrhythmias, which are broadly defined as a set of conditions in which the electrical activity of the heart is irregular, or faster or slower than normal. This type of heart disease afflicts 14.4 million Americans, or one in 18. Two of the most prevalent and deadly types of arrhythmias today are Atrial Fibrillation (AF) and Ventricular Tachycardia (VT).
BSGM PURE EP is designed to improve the clarity of clinical signals available for EP studies and cardiac catheter ablation. It is a surface electrocardiogram (ECG) and intracardiac multichannel recording and analysis system designed to assist electrophysiologists in making clinical decisions in real-time by acquiring and displaying high-fidelity cardiac signal recordings and providing clarity of data which may be used to guide the EP's in identifying ablation targets; areas of tissue to treat that otherwise create a heart rhythm disturbance (arrhythmia). BioSig believes this information is not always easily obtained, if at all, from any other EP equipment in the market today.
BSGM PURE EP is designed to improve the clarity of clinical signals available for EP studies and cardiac catheter ablation. It is a surface electrocardiogram (ECG) and intracardiac multichannel recording and analysis system designed to assist electrophysiologists in making clinical decisions in real-time by acquiring and displaying high-fidelity cardiac signal recordings and providing clarity of data which may be used to guide the EP's in identifying ablation targets; areas of tissue to treat that otherwise create a heart rhythm disturbance (arrhythmia). BioSig believes this information is not always easily obtained, if at all, from any other EP equipment in the market today.
BSGM is a medical device company that is developing a proprietary technology platform designed to improve the rapidly growing $3 billion electrophysiology (EP) marketplace. Led by a proven management team and a veteran, independent Board of Directors, Minneapolis-based BioSig is preparing to commercialize its PURE EP System.
BSGM is a medical device company that is developing a proprietary technology platform designed to improve the rapidly growing $3 billion electrophysiology (EP) marketplace. Led by a proven management team and a veteran, independent Board of Directors, Minneapolis-based BioSig is preparing to commercialize its PURE EP System.
BSGM is generating a lot of buzz on Twitter.
BSGM is generating a lot of buzz on Twitter.
BSGM is on high alert. Watch for profits.
BSGM is on high alert. Watch for profits.
BGSM is on my radar today.